Stockreport

Eleven Biotherapeutics Announces Pricing of $10.0 Million Offering Priced At-the-Market

ELEVEN BIOTHERAPEUTICS  (EBIO) 
Last eleven biotherapeutics earnings: 5/15 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.elevenbio.com/investor-relations
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical company advancing next-generation antibody-drug conju [Read more]